Skip to main content
. 2013 Apr 17;8(4):e61448. doi: 10.1371/journal.pone.0061448

Figure 3. Cumulative incidence of hepatocellular carcinoma (HCC) by sum scores of each model at study entry.

Figure 3

Classical model (Risk Model I, A), the model combining liver-related seromarkers without HBV seromarkers of HBeAg serostatus and serum HBV DNA level (Risk Model II, B), and the model combining liver-related seromarkers with HBV seromarkers (Risk Model III, C).